No Data
No Data
Express News | HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $50 Price Target
Biomea Fusion Is Maintained at Neutral by JP Morgan
Biomea Fusion Is Maintained at Neutral by JP Morgan
Express News | JP Morgan Maintains Neutral on Biomea Fusion, Raises Price Target to $15
Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA), Repligen (RGEN) and Agenus (AGEN)
Barclays Sticks to Its Buy Rating for Biomea Fusion (BMEA)
Biomea Fusion GAAP EPS of -$1.09 Misses by $0.02
No Data